+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Royalty Rates in Pharmaceutical and Biotechnology Deals 2010-2025 - Product Thumbnail Image

Royalty Rates in Pharmaceutical and Biotechnology Deals 2010-2025

  • Report
  • September 2025
  • 950 Pages
  • Global
From
From
Alzheimer's Disease Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Alzheimer's Disease Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Alzheimer's Therapeutics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Alzheimer's Therapeutics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Hematology Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Hematology Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 150 Pages
  • Global
From
Alzheimer's Drugs Market Report 2025 - Product Thumbnail Image

Alzheimer's Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Loading Indicator